Journal profile · CLINICAL NEUROLOGY-NEUROSCIENCES

Multiple Sclerosis Journal

ISSN 1352-4585 · eISSN 1477-0970 · SAGE Publications Ltd · ENGLAND

Journal homepage ↗Submission system ↗Special issues ↗

Multiple Sclerosis Journal: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.88; hybrid open access; APC about USD 4,400; review 3–8 weeks (community reports); community-reported acceptance: fairly easy; 235 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.88Latest value listed by LetPub

CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine

Review time3–8 weeksCommunity average

APCUSD 4,400Hybrid journal: charged only for open-access articles

AcceptanceFairly easyCommunity average

Articles per year2352025 · OpenAlex count

Scope

Aims, scope and focus

Multiple Sclerosis Journal is published by SAGE Publications Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Polyomavirus and related diseases, together about 59.8% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)

Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and oth...

From the journal's Aims & Scope

Research area (LetPub): CLINICAL NEUROLOGY-NEUROSCIENCES

Editor-in-chief Jaume Sastre-GarrigaPublisher website

Editorial board by country: none in mainland China; most named United States 16, United Kingdom 10, Italy 6, Spain 6, Canada 5 (64 members with a country) Editorial board ↗Publisher website · 2026-10-01

Main research topics OpenAlex counts of recent articles; shares are approximate

Multiple Sclerosis Research StudiesMedicine44.3%
Peripheral Neuropathies and DisordersMedicine10.4%
Polyomavirus and related diseasesMedicine5%
Systemic Sclerosis and Related DiseasesMedicine4.8%
Systemic Lupus Erythematosus ResearchMedicine4.7%
Amyotrophic Lateral Sclerosis ResearchMedicine3.3%
Rheumatoid Arthritis Research and TherapiesMedicine2.7%
Long-Term Effects of COVID-19Medicine2.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Clinical Neurology	Zone 2
Minor	Neurosciences	Zone 2

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Clinical Neurology	Zone 2
Minor	Neurosciences	Zone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Clinical Neurology	Zone 2
Minor	Neurosciences	Zone 2

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor: 3.88LetPub · 2026-09-13
Impact factor (publisher): 4.1Publisher website · 2026-10-01
5-year impact factor (publisher): 4.9Publisher website · 2026-10-01
CiteScore 2026-06: 8.8LetPub · 2026-09-13
SJR 2026-06: 1.68LetPub · 2026-09-13
SNIP 2026-06: 1.29LetPub · 2026-09-13
h-index: 111LetPub · 2026-09-13
h-index: 182OpenAlex · 2026-10-01
i10-index: 4,230OpenAlex · 2026-10-01
2-year mean citedness: 3.46OpenAlex · 2026-10-01
Self-citation rate: 9.8%LetPub · 2026-09-13
Share of gold OA articles: 35.48%LetPub · 2026-09-13

Volume

Articles per year: 160LetPub · 2026-09-13

Articles by year OpenAlex count · 7,456 in total · the current year is incomplete

Year	Articles	Open access	Citations
2026	194	108	63
2025	235	188	634
2024	266	202	1,711
2023	215	178	2,407
2022	217	104	3,280
2021	254	137	5,171

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports): 3–8 weeksLetPub · 2026-09-13
Average acceptance (community reports): Fairly easyLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

Source	APC	Fee waiver	License	Observed
OpenAlex	USD 4,400 / GBP 3,226	—	—	2026-10-01

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher: SAGE Publications Ltd
Country or region: ENGLAND
Language: English
ISSN: 1352-4585
Electronic ISSN: 1477-0970
Official links: Journal homepage ↗OpenAlex
Submission system ↗LetPub
Special issues ↗Publisher website

FAQ

Frequently asked questions about Multiple Sclerosis Journal

What CAS zone is Multiple Sclerosis Journal in?

In the 2025 upgraded edition of the CAS Journal Ranking, Multiple Sclerosis Journal is in Zone 2 of Medicine, and in Zone 2 of the minor category Clinical Neurology / Neurosciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Multiple Sclerosis Journal?

The latest impact factor listed by LetPub is 3.88; CiteScore 8.8, h-index 182.

How long does peer review take at Multiple Sclerosis Journal?

Authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Multiple Sclerosis Journal based?

Of the 64 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (16), United Kingdom (10) and Italy (6). Counted from the institutions listed on the board page; for reference only.

Which databases index Multiple Sclerosis Journal?

According to LetPub and DOAJ records, Multiple Sclerosis Journal is indexed in SCIE and Scopus.

Is Multiple Sclerosis Journal open access, and what is the APC?

Multiple Sclerosis Journal is a hybrid journal. For open-access publication: APC about USD 4,400.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: 2026-10-01.